MLYS
NASDAQ HealthcareMineralys Therapeutics, Inc. - Common Stock
Biotechnology
📊 Market Data
| Price | $26.99 |
|---|---|
| Volume | 1,148,741 |
| Market Cap | 2.14B |
| Beta | 0.570 |
| RSI (14-Day) | 45.5 |
| 200-Day MA | $28.90 |
| 50-Day MA | $30.87 |
| 52-Week High | $47.65 |
| 52-Week Low | $10.44 |
| Forward P/E | -12.11 |
| Price / Book | 3.70 |
🎯 Investment Strategy Scores
How MLYS scores across each investment strategy. Higher is better for that strategy's goals.
💰 Dividend Daddy
43/100
High dividend yield + low volatility
🚀 Moon Shot
25/100
High growth potential (high beta + oversold)
🔪 Falling Knife
47/100
Contrarian plays (oversold + below moving average)
🎈 Over-Hyped
64/100
Overbought stocks (potential short candidates)
🐋 Institutional Whale
41/100
Large-cap, institutional-quality stocks
Find MLYS in your text
Paste any text on the homepage — the tool will extract MLYS and other hidden tickers.
Disclaimer: This data is for educational and entertainment purposes only and does not constitute financial advice. Market data may be delayed. Always do your own research before making investment decisions.